• Contact Us
  • Environment
  • News
  • Careers
Kent Pharmaceutical Logo
  • Home
  • About Us
  • Our Products
  • Manufacturing
  • Sales
  • NHS
FDA acts to bolster supply of critically needed cancer drugs  |  How good cholesterol turns bad  |  BRILINTA® added to American College of Chest Physicians recommendations  |  Pfizer and Hisun announce progress on potential joint venture  |  Positive One Year results From Phase 3 Study in Central Retinal Vein Occlusion of VEGF Trap-Eye  |  Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia  |  EU and US Regulatory Update - Tykerb/Tyverb® (lapatinib)  |  Positive top-line result for UCB's Cimzia® in psoriatic arthritis  |  Video games lead to new paths to treat cancer  |  Merck Establishes Joint Venture with Supera Farma  |   rss

Success is the best medicine

Site Map

Site Map

  • About Us
    • Careers
    • Community
    • Contact Us
    • Environment
    • News
  • Home
  • Hospital Contracts
    • Over Labelling
    • Ready to Dispense
    • Special Services
  • Kent Connect
  • Manufacturing
    • Business Development
    • Repackaging
    • Warehouse
  • News
  • Our Services
  • Products
    • Anaesthetics
    • Dressings and Surgicals
    • Early Bird
    • Generics
    • Kent Label
    • OTC
    • P.I.s
    • Safe-Inject
    • Special Services
    • UK Packs
  • Retail
    • Customer Services
    • Dispensing Doctors
    • Telesales
    • Wholesale
  • Security and Privacy
  • Site Map
  • Terms and Conditions

 

  • Kent Connect
  • Manufacturing
  • NHS
  • Repackaging
  • Products
  • Retail
  • Wholesale
  • About Us
  • Careers
  • Community
  • Contact Us
  • Environment
  • Security & Privacy
  • Terms & Conditions

Contact Us
T.0845 437 5565
F.0845 437 5567
info@kentpharm.co.uk
© 2012 Kent Pharmaceuticals Ltd.

Website Design and Development
WillCreate
Sitemap